|

RP2 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 2/3: 1

Top Sponsors

  • Replimune Inc.2

Indications

  • Cancer2
  • Liver Disease1
  • Metastatic Uveal Melanoma1
  • Biliary Tract Cancer1
  • Liver Cancer1

Scottsdale, Arizona1 trial

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

HonorHealth Research Insisute

Phase 2/3

Beverly Hills, California1 trial

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Beverly Hills Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.